Smithfield Trust Co - CHINA BIOLOGIC PRODS INC ownership

Quarter-by-quarter ownership
Smithfield Trust Co ownership history of CHINA BIOLOGIC PRODS INC
ValueSharesWeighting
Q2 2017$56,000
-1.8%
499
-12.5%
0.01%
-11.1%
Q1 2017$57,000
-12.3%
570
-5.0%
0.01%
-18.2%
Q4 2016$65,000
+32.7%
600
+50.4%
0.01%
+22.2%
Q3 2016$49,0003990.01%
Other shareholders
CHINA BIOLOGIC PRODS INC shareholders Q3 2023
NameSharesValueWeighting ↓
WARBURG PINCUS LLC 10,989,200$1,049,578,0007.88%
RUDMAN ERROL M 110,201$10,525,0003.65%
Ativo Capital Management LLC 59,789$5,710,0002.24%
OBERWEIS ASSET MANAGEMENT INC/ 56,200$5,368,0001.51%
Granite Point Capital Management, L.P. 40,000$3,820,0001.40%
Cormorant Asset Management, LP 76,500$7,307,0001.13%
Spark Investment Management LLC 52,800$5,031,0000.70%
Grandeur Peak Global Advisors, LLC 33,050$3,157,0000.67%
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC 198,454$18,954,0000.66%
Visium Asset Management, LP 438,008$41,834,0000.62%
View complete list of CHINA BIOLOGIC PRODS INC shareholders